© 2026 NPR Illinois
For your right to be curious.
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Build a transformational philanthropy program for this trusted NPR affiliate.
Seeking a 100% major gift fundraiser passionate about public media to develop relationships with people who support an informed and civil central Illinois.
Hire will have community visibility, many prospects, and professional resources.
Interviews in progress, open until filled. Apply now.

Are you availabile to be a local fill-in anchor on Morning Edition and/or All Things Considered?
Must be available with notice either weekdays from 5:30 to 9 a.m. and/or 3:30 to 6 p.m.
Apply by June 5, 5 p.m.

FDA Expected To Authorize Moderna Vaccine For Emergency Use

NPR
Published December 18, 2020 at 11:20 AM CST
A syringe and a bottle reading "Vaccine COVID-19" next to the Moderna biotech company logo. (Joel Saget/AFP via Getty Images)
A syringe and a bottle reading "Vaccine COVID-19" next to the Moderna biotech company logo. (Joel Saget/AFP via Getty Images)

Hope is growing as more health care workers get shots of Pfizer and BioNTech’s coronavirus vaccine, just as a second vaccine from Moderna is on the verge of being authorized for emergency use in the U.S.

A panel of advisors to the Food and Drug Administration voted Thursday to recommend that Moderna’s vaccine be approved. The agency is expected to act on that as soon as Friday.

Here & Now‘s Lisa Mullins speaks with Walter Orenstein, associate director of the Emory Vaccine Center at Emory University in Atlanta. Orenstein is advising Moderna and is also a participant in the company’s vaccine trial.

This article was originally published on WBUR.org.

Copyright 2021 NPR. To see more, visit https://www.npr.org.